72
Views
6
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Influence of the CYP17 polymorphism on vasomotor symptoms in postmenopausal women: a pilot study

, , , , , & show all
Pages 537-543 | Received 22 Nov 2010, Accepted 13 Dec 2010, Published online: 13 Mar 2011

  • Oldenhave A, Jasszmann LJ, Haspels AA, . Impact of climacteric on well-being: a survey based on 5213 women 39 to 60 years old. Am J Obstet Gynecol 1993;168:772–80
  • Galhardo CL, Soares JM Jr, Simo˜es RS, Haidar MA, Rodrigues de Lima G, Baracat EC. Estrogen effects on the vaginal pH, flora and cytology in late postmenopause after a long period without hormone therapy. Clin Exp Obstet Gynecol 2006;33:85–9
  • Avis NE, Crawford S, Stellato R, Longcope C. Longitudinal study of hormone levels and depression among women transitioning through menopause. Climacteric 2001;4:243–9
  • Joffe H, Hall JE, Soares CN, . Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care. Menopause 2002;9:392–8
  • Whiteman MK, Staropoli CA, Benedict JC, . Risk factor for hot flashes in midlife women. J Womens Health (Larchmt) 2003; 12:459–72
  • Kronemberg F, Downey JA. Thermoregulatory physiology of menopausal hot flashes: a review. Can J Physiol Pharmacol 1987; 65:1312–24
  • Freedman RR. Hot flashes revisited. Menopause 2000;7:3–4
  • Freedman RR. Physiology of hot flashes. Am J Hum Biol 2001; 13:453–64
  • Silva NL, Boulant JA. Effects of testosterone, estradiol and temperature on neurons in preoptic tissues slices. Am J Physiol 1986;250:R625–32
  • Altura BM. Sex as a factor influencing the responsiveness of arterioles to catecholamines. Eur J Pharmacol 1972;20:261–5
  • Freedman RR, Blacker CM. Estrogen raises the sweating threshold in postmenopausal women with hot flashes. Fertil Steril 2002; 77:487–90
  • Mitrunen K, Hirvonen A. Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes envolved in oestrogen biosynthesis and metabolism. Mut Res 2003;544: 9–41
  • Huber JC, Schneeberger C, Tempfer CB. Genetic modeling of the estrogen metabolism as a risk factor of hormone-dependent disorders. Maturitas 2002;42:1–12
  • Erlik Y, Meldrum DR, Judd HL. Estrogen level in post-menopausal women with hot flashes. Obstet Gynecol 1982; 59:403–4
  • Carey AH, Waterworth D, Patel K, . Polycystic ovaries and premature male pattern baldness are associated with an allele of the steroid metabolism gene CYP17. Hum Mol Genet 1994; 3:1873–6
  • Sharp L, Cardy AH, Cotton SC, . CYP17 gene polymorphisms: prevalence and association with hormone levels and related factors. A huge review. Am J Epidemiol 2004; 160:729–40
  • Malacara JM, Perez-Luque EL, Martinez-Garza S, . The relationship of estrogen receptor-polymorphism with symptoms and other characteristics in post-menopausal women. Maturitas 2004;49:163–9
  • Visvanathan K, Gallicchio L, Schilling C, . Cytochrome gene polymorphisms, serum estrogens, and hot flushes in midlife women. Obstet Gynecol 2005;106:1372–81
  • Kang D. Genetic polymorphisims and cancer susceptibility of breast cancer in Korean women. J Biochem Mol Biol 2003;36: 28–34
  • Patriarca MT, Rodrigues de Lima G, Stavale JN, . Ultrasonographic and morphological studies of the postmeno pausal endometrium using unopposed estrogen replacement therapy with regular pause. A prospective preliminary study. Eur J Obstet Ginecol Reprod Biol 2001;98:119–23
  • Fardellone P. Predicting the fracture risk in 2008. Joint Bone Spine 2008;75:661–4
  • Fay MP, Proschan MA. Wilcoxon–Mann–Whitney or t-test? On assumptions for hypothesis tests and multiple interpretations of decision rules. Stat Surv 2010;4:1–39
  • Miyoshi Y, Noguchi S. Polymorphisms of estrogen synthesizing and metabolizing genes and breast cancer in Japanese women. Biomed Pharmacother 2003;57:471–81
  • Haiman CA, Hankinson SE, Spiegelman D, . The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer. Cancer Res 1999;59:1015–20
  • Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002:94:606–16
  • Tworoger S, Chubak J, Aiello E, . Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women. Cancer Epidemiol, Biomarkers Prevention 2004;13:94–101
  • Jernstrom H, Vesprini D, Bradlow HL, . Re: CYP17 promoter polymorphism and breast cancer in Australian women under age forty years. J Natl Cancer Inst 2001;93:554–5
  • Feigelson HS, McKean-Cowdin R, Pike MC, . Cytochrome P450c17 alpha gene (CYP17) polymorphism predicts use of hormone replacement therapy. Cancer Res 1999;59:3908–10

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.